Lilly Wins Fibromyalgia Management Indication For Cymbalta
This article was originally published in The Pink Sheet Daily
Executive Summary
The blockbuster SNRI is second into the fibromyalgia space, following Pfizer’s Lyrica.
You may also be interested in...
Forest Savella’s Launch For Fibromyalgia: Many Sales Forces, Single Claim
Forest's promotional messaging for the launch of its fibromyalgia drug Savella (milnacipran) has a somewhat unusual emphasis - the product's limited utility
Forest Savella’s Launch For Fibromyalgia: Many Sales Forces, Single Claim
Forest's promotional messaging for the launch of its fibromyalgia drug Savella (milnacipran) has a somewhat unusual emphasis - the product's limited utility
FDA Clears Forest’s Savella, The First Fibromyalgia-Only Drug
The selective serotonin and norepenephrine reuptake inhibitor will require a MedGuide, and thus a REMS.